1608464-07-8

Basic information

• Product Name: 2-(10-(4-((S)-3-(2-((S)-3-(biphenyl-4-yl)-2-hydroxypropoxy)ethoxy)-2-hydroxypropyl)-1H-1,2,3-triazol-1-yl)decyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
• Synonyms: 2-(10-(4-((S)-3-(2-((S)-3-(biphenyl-4-yl)-2-hydroxypropoxy)ethoxy)-2-hydroxypropyl)-1H-1,2,3-triazol-1-yl)decyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
• CAS NO: 1608464-07-8
• Molecular Weight: 717.903
• Mol File: 1608464-07-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(10-(4-((S)-3-(2-((S)-3-(biphenyl-4-yl)-2-hydroxypropoxy)ethoxy)-2-hydroxypropyl)-1H-1,2,3-triazol-1-yl)decyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(10-(4-((S)-3-(2-((S)-3-(biphenyl-4-yl)-2-hydroxypropoxy)ethoxy)-2-hydroxypropyl)-1H-1,2,3-triazol-1-yl)decyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione(1608464-07-8)
• EPA Substance Registry System: 2-(10-(4-((S)-3-(2-((S)-3-(biphenyl-4-yl)-2-hydroxypropoxy)ethoxy)-2-hydroxypropyl)-1H-1,2,3-triazol-1-yl)decyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione(1608464-07-8)

Safety Data

• Hazardous Substances Data: 1608464-07-8(Hazardous Substances Data)

Upstream product

• 1608463-87-1 (S)-2-((S)-5-(biphenyl-4-ylmethyl)-2,4,7,10-tetraoxaundecan-11-yl)oxirane 
• 1608463-86-0 (S)-5-(biphenyl-4-ylmethyl)-11-phenyl-2,4,7,10-tetraoxaundecane 
• 1608463-85-9 (S)-1-(2-(benzyloxy)ethoxy)-3-(biphenyl-4-yl)propan-2-ol 
• 406218-43-7 (S)-2-((2-(benzyloxy)ethoxy)methyl)oxirane 
• 81575-48-6 2-(10-bromodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione 
• 1608463-88-2 (5S,12S)-5-(biphenyl-4-ylmethyl)-12-(prop-2-ynyl)-2,4,7,10,13,15-hexaoxahexadecane 
• 2834-05-1 11-bromoundecanoic acid 
• 605-94-7 2,3-Dimethoxy-5-methyl-1,4-benzoquinone 

Relevant articles and documents

Biological evaluation of new mimetics of annonaceous acetogenins: Alteration of right scaffold by click linkage with aromatic functionalities

A small library of analogues of annonaceous acetogenins through click linkage with aromatic moieties is established using a convergent modular fragment-assembly approach. These analogues exhibited low micromolar inhibitory activities against the proliferation of several human cancer cell lines. Structure-activity relationship (SAR) of these analogues indicates that replacement of the methoxy groups of ubiquinone ring with methyl groups is proved to be a useful strategy for improving the anticancer activity of quinone-acetogenin hybrids.